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Abstract 
Background: A new indole derivative with the lab code-number SS-68 demonstrates a 
significant antiarrhythmic (anti-fibrillation) activity associated with the predominant influence on 
potassium and calcium conductivity of cardiomyocytes plasmalemmas. The preliminary data give 
evidence of SS-68 possessing an antiaggregant activity.  
Methods: The influence of SS-68 on the platelet formation stage of hemostasis was determined 
by assessment of the anti-platelet effect (measuring platelet aggregation with Born/ O’Brien 
method), the dynamics of intracellular concentration of calcium ions in platelets was studied with 
FURA-2/АМ fluorescent probe.  
Results: Relative efficiency of the SS-68 indole derivative influence on platelet aggregation with 
the use of various inducers decreases in the following order: collagen > serotonin > ADP. The 
influence of SS-68 on platelet activity is characterized by pleiotropic effects: calcium-blocking 
effect, potentiation of cAMP-response, suppression of intracellular mechanisms of transmitting a 
stimulating signal, caused by the activation of collagen receptors.  
Conclusion: G-proteins are the most likely molecular targets of pleiotropic antiaggregant effect 
of SS-68. A more than threefold increase in the anti-platelet effect of SS-68 in vivo suggests the 
development of an active metabolite (metabolites).  
 Key words: SS-68 compound; platelet aggregation; disaggregation; intracellular calcium; 
molecular targets of anti-platelet effect.  
Background 
In our previous research work, we discussed the 
possibility of the new indole derivative with the lab 
code-number SS-68, produced in the Research 
Institute of Physical and Organic Chemistry of 
Southern Federal University (Rostov-on Don), to 
demonstrate a significant antiarrhythmic (anti-
fibrillation) activity associated with the predominant 
influence on potassium and calcium conductivity of 
cardiomyocytes plasmalemmas  [1].  Besides,  the 
SS-68 compound possesses a tropic effect on alpha- 
and beta-adrenoreceptors [2]. 
The aim of the present research work is to study 
the influence of SS-68 on the platelet formation stage 
of hemostasis. For that purpose, we used a number of 
experimental conditions, modelling the platelets 
activation. The platelets reaction on external stimuli 
is determined by the correlation of extracellular 
signals, activating and inhibiting the cells activity [3]. 
The physiological stimulants of platelets activity may 
be divided into two groups: 1) weak agonists – ADP 
(in concentration < 1 mcM), vasopressin, adrenalin, 
serotonin; 2) strong agonists – thrombin, collagen, 
thromboxane A2, platelet activating factor (PAF), 
ADP (> mcM). The group of antagonists includes: 
prostaglandin I2, (prostacyclin, PGI2), prostaglandin 
Rus. 
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D2 (PGD2), NO (nitrogen oxide, endothelial relaxing 
factor). They also may be classified according to their 
origin: plasma components (thrombin, plasmin, 
catecholamine), vascular (PGI2, NO, collagen), 
thrombocytic (ADP, serotonin, ТхА2, PAF).  
Methods 
1. Preparing suspension of washed platelets from
whole blood. 
1.1. Platelet-rich plasma (PRP) preparation. The 
blood (10 ml) was collected from the basilic vein into 
a plastic tube containing 1.5 ml of the additive 
(glucose – 5 mM; sodium citrate – 85 mM; citric acid 
(pH 6.55 – 65 mM). To obtain PRP, the blood was 
centrifuged at 200 g for 10 minutes, then 2.5 ml of 
the supernatant was carefully collected. The cell 
count was performed in the Goryaev chamber. To 
obtain plasma with platelet count of  250-350109/l, 
PRP was diluted with platelet-poor plasma.  
1.2. Platelet-poor plasma preparation (PPP). 
The supernatant, remained after PRP 
preparation, was centrifuged at 600 g for 20 minutes, 
then the transparent supernatant was collected from 
the tube.  
1.3. The method of washed platelets preparation.  
The method included sequential washing of a 
PRP sample in three modified Tyrode's solutions 
containing: 
 Т1 – 2.8 mM KCl, 2 mM MgCl2, 0.36 mM
NaH2PO4, 138 mM NaCl, 0.2 mM EGTA, 10 mM 
HEPES; 
 T2 – the composition is the same as in T1,
but does not contain EGTA; 
 T3 – 2.8 mM KCl, 0.5 mM MgCl2, 0.36 mM
NaH2PO4, 138 mM NaCl, 10 mM HEPES, 1 mM 
CaCl2. 
Before the investigation, the following 
substances were added to the solutions: to T1 and   
T2 – glucose to the concentration of 5 mM, bringing 
pH to 6.55; to T3 – pH 7.4.  
In the process of washing platelets, the cell 
resuspension was performed in a slightly lower 
solution volume by gently shaking the tube for 
several minutes.   
2. Measuring platelet aggregation with the Born/
O’Brien method. 
To assess the SS-68 influence on the induced 
change in light transmission, there were used the 
following aggregation parameters: 1) the maximum 
range – a percent increase of light transmission after 
adding an inducer; 2) the time between the start of 
aggregation and reaching the maximum of light 
transmission; 3) the maximum speed of aggregation.  
The in vitro experiments were performed on 
rabbits weighing 2.5-3 kg, and in vivo – on male rats 
weighing 250-300 g. The blood for in vitro 
experiments was collected from the rabbits’ auricular 
vein, and in vivo experiments – from the rats’ ventral 
aorta. The animals were anesthetized with chloral 
hydrate (400 mg/kg intraperitoneally) and were 
stabilized with 3.8% solution of sodium citrate at the 
ratio of 9:1. The SS-68 influence on intravascular 
aggregation of blood plates was measured in 2 hours 
after oral administration of the substance in the dose 
equimolar to 19 mg/kg of acetylsalicylic acid (the 
dose is equivalent to the ErC50 dose of 
acetylsalicylic acid obtained in in vitro experiments).  
In the course of the investigation, 300 mcl of 
platelet-rich plasma and the SS-68 solution in 
concentration of 1х10-4M (in in vitro experiments) 
were sequentially introduced into the aggregometer 
measuring cell. The samples were incubated in the 
thermostat of the aggregometer at 37
0
C for 5 minutes. 
After starting the recording of the aggregatogram, on 
the 10
th
 second of the registration process, the 
aggregation inducer (adenosine 5'-phosphoric acid 
(ADP) in final concentration of 5 mcM was added to 
the measuring cell. Acetylsalicylic acid was selected 
as a comparator agent.  
3. The method of measuring intracellular
calcium ion concentration in platelets with  
FURA-2/АМ fluorescent probe was earlier described 
in [4, 5].  
4. The statistical processing of the results.
The calculation of confidence intervals of 
experimental values and confidence assessment of 
their differences were performed with nonparametric 
Wilcoxon-Mann-Whitney paired test (in processing 
data of in vivo experiments) and Student t-test (in in-
vitro experiments), with the confidence level p=0.05.  
Results 
1. Studying the SS-68 influence on platelet
aggregation. 
1.2. The SS-68 influence on platelet spontaneous 
aggregation. Any significant changes in the 
aggregation parameters when using SS-68 in the 
concentration range between 0.01-1.0 mcM were not 
identified.  
1.3. Studying the SS-68 influence on ADP-
induced platelet aggregation. ADP is the most 
widespread inducer of blood plates used in in vitro 
experiments. According to the data published in the 
media, most researches on the drugs influence on the 
platelet function were conducted with the use of the 
above mentioned inducer [6]. This is explained by the 
fact that ADP is a universal endogenous regulator of 
platelets physiological activity, and it enables to 
separately register both reversible and irreversible 
phases of aggregation.  
With low aggregate  concentrations (below 
510-7М ADP) there can be observed reversible 
aggregation, characterized by small aggregates (low-
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amplitude fluctuations on the curve), containing 3-20 
blood plates. Subsequent disaggregation manifests 
itself in a rapid decrease of the light transmission 
which does not reach the original level (Fig.1, the 
lower curve). With a higher dose (10
-6
 М ADP), there 
were registered the first and the second waves of 
aggregation. And finally, the use of ADP in 
concentration of 5 mcM increased the transmission of 
light in the sample without its subsequent decrease, 
that characterizes irreversible aggregation (Fig. 1, the 
upper curve).  
Fig. 1. ADP-induced platelet aggregation. 
Note. The ordinate shows the change transmission of light, rel. units. 
Conditions: the concentration of platelets in the sample is 250-350109 cells/ l; Mixing speed – 800 rpm; Temperature – 370С 
The study of the SS-68 influence on ADP-
induced platelet aggregation (with ADP 
concentration of 1 mcM) has established, that in 
concentration of 0.01 and 0.03 mcM, SS-68 did not 
produce any optical density changes. Inducement of 
SS-68 in concentration of 0.1 and 0.5 mcM resulted 
in a significant decrease in the sphere-forming 
reaction and the appearance of 5-15 with a delay of 
aggregation initiation. The change in the other 
aggregation indicators was unstable: the decrease in 
the maximum amplitude of aggregation and its speed 
were of individual character, ranging 10-20%.   
Apparently, the absence of significant changes in 
the reversible phase of aggregation with present SS-68 
may be explained by particular qualities of the 
mechanism of ADP-induced aggregation of cells. The 
ADP platelets induction (1 mcM and less) is known to 
be mediated by activation of P2-purinoreceptors that are 
at the same time Ca-channels of the cell membrane [7]. 
Thus, the influence of ADP low concentrations on 
platelets is not mediated by formation of secondary 
messengers, and is not regulated by any known G-
protein – the structures considered to be the target of the 
SS-68 activity [1, 2]. 
The results of the study of antiplatelet activity of 
SS-68 compared with antiplatelet activity of 
acetylsalicylic acid (ASA) are presented in Table 1 and 
Table 2. The conducted experiments have enabled to 
identify antiaggregant activity of SS-68. However, the 
platelet aggregation inhibition under the influence of 
SS-68 did not exceed 50% and gave way to the 
comparator agent – acetylsalicylic acid (Table 1).  
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Table 1 
Antiaggregant activity of SS-68 on the model of ADP-induced platelet aggregation in vitro 
Agent 
Δ% of inhibition 
IC50 
10
-4
10
-5
10
-6
SS-68 42.1±1.1* - - - 
ASA
1
 52.06±4.2* 20.8±3.5* 4.6±1.7* 1.0410-4 
Note: 
1
 Acetylsalicylic acid; 
* The figures are credible compared to control (Mann-Whitney test p < 0.005)
In in vivo experiments, the antiaggregant activity of SS-68 was three times as active as the comparator 
agent (Table 2).  
Table 2 
Antiaggregant activity of SS-68 on the model of ADP-induced 
platelet aggregation in vivo 
Agent Dose, mg/kg Δ, % of inhibition 
SS-68 35.8
1
93.6±1.6* 
ASA 19 29.7±8.1* 
Note: 
1 
Dose equimolar to the dose of acetylsalicylic acid; 
* The figures are credible compared to control (Mann-Whitney test p < 0.005)
1.4 The study of the SS-68 influence on 
serotonin-induced platelet aggregation. 
According to current data, serotonin (5-
hydroxy-tryptamine) belongs to weak inducers [8]. 
5-НТ2А type of serotonin receptors are present on 
the platelet cell membrane. It was shown, that in 
the process of binding serotonin with receptors, the 
activation of phosphoinositides exchange occurs, 
resulting in formation of secondary messengers – 
inositol-3-phosphate and diacylglycerol which 
mediate the cell response, primarily, at the expense 
of intracellular calcium mobilization. That is why 
we considered it best that we study the SS-68 
influence on platelet aggregation induced by 
serotonin.  
The data on the SS-68 influence on serotonin-
induced platelet aggregation (serotonin was used in 
concentration of 10
-5
 М) have shown, that in 
concentration of 0.1-1.0 mcM, SS-68 did not 
change any parameters of serotonin-induced 
platelet aggregation. The reliable difference from 
control values was observed when using SS-68 in 
high concentration of 5 mcM: the degree of 
maximum amplitude suppression ranged 10-15% 
compared to control; the time between aggregation 
initiation and achieving the amplitude maximum, 
as well as the maximum speed of aggregation were 
decreased by 11% and 9% respectively. The 
change in aggregation parameters had a positive 
correlation with the increase in concentration of 
SS-68 up to 15 mcM.  
Thus, in serotonin-induced aggregation, SS-68 
demonstrated a suppressive activity on aggregation 
in concentration of 5 mcM. Besides, there was 
noted some dependence of the effect on the 
concentration of SS-68 in the incubation medium.  
So far, it is known that platelet activation by 
serotonin is regulated through сAMP-dependent 
pathways; it is blocked by AC-stimulators and 
PDE сAMP-inhibitors. The activity of adenylate 
cyclase biocatalysts is regulated through the 
functioning of the regulatory G-proteins, that can 
mediate a more pronounced influence of SS-68 on 
aggregation induced by serotonin. 
1.5. The study of the SS-68 influence on 
collagen-induced platelet aggregation 
The interaction of collagen with platelets 
receptors changes the form of cells and causes 
release reaction and irreversible aggregation. 
Collagen-induced activation of platelets includes 
the synthesis and release of thromboxane from 
cells – the activation factor of platelets, 
prostaglandins, ADP, and serotonin. The specified 
agents cause cells reaction through a receptor-
mediated calcium entry from outside and ion exit 
from intracellular depots [9].   
In this series of experiments, aggregation was 
induced with collagen in concentration of 5 mcg/ 
ml. Collagen-induced aggregation is characterized 
by a latent period (10-15 c), it is monophasic and 
irreversible. A typical curve of changes in light 
transmission induced by collagen is shown in 
Figure 2.  
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Fig. 2. Collagen-induced change in light transmission of a platelet-rich plasma. 
Note. Conditions: collagen – 5 mcg / ml; 250 – 350109 cells/liter; Mixing speed – 800 rpm; Temperature – 370С 
The experiments revealed that the SS-68 
effects coincide with the results of experiments, in 
which ADP and serotonin were used as inducers.  
The results of this series of experiments 
demonstrate that the ability to decrease the 
platelets function in SS-68 on collagen-induced 
aggregation manifested itself to the most extent. 
Relative effectiveness of the SS-68 influence on 
platelet aggregation with the use of various 
inducers decreases in the following order: collagen 
> serotonin >>ADP. That is why we have chosen a 
model of collagen-induced platelet aggregation for 
a detailed study of the mechanisms of the SS-68 
activity.  
Figure 3 demonstrates dependence of the light 
transmission speed (A) and maximum amplitude of 
aggregation (V) on concentration of SS-68. The 
analysis of the obtained data attracts attention to 
the dose dependence of the SS-68 effect. 
Fig. 3. Dependence of the light transmission speed (A) and maximum amplitude of aggregation (V) 
on concentration of SS-68  
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To determine the mechanism of the SS-68 
activity, we have conducted an inhibitory analysis. 
The results of this analysis are shown in Figure 4, 
in the Lineweaver-Burk plot. The lower straight 
line presents the dependence of aggregation speed 
from inducer concentration; the upper straight lines 
characterize a joint effect of collagen and SS-68. 
The straight lines meet at one point on the ordinate 
axis, that corresponds to the case of non-
competitive inhibition. Therefore, SS-68 does not 
change receptors affinity to collagen, they decrease 
the number of “active” and functioning receptors. 
The increase in concentration of SS-68 from 1 to 
10 mcM results in the increase of the effect. 
Fig. 4. Dependence of the platelet aggregation rate on the inductor concentration in the absence of (1) 
 and in the presence of SS-68 (2-1 μM, 3-5 μM), represented in the coordinates of Linuiver-Burke 
1.6 The study of the SS-68 influence on 
platelets disintegration.  
The functional activity of platelets is determined 
by a correlation of factors of activation and inhibition 
[10]. The mechanism of suppressing SS-68 
aggregation may be connected with activation of 
disintegration processes. This issue will be discussed 
in the second part of the research work. 
Disaggregation was induced with various 
inducers, different in their mechanism of activity, 
including nitroprussid sodium and adenosine. 
Nitroprusside sodium stimulates guanylate cyclase, 
providing the intracellular increase in cGMP [10]. 
The mechanism of adenosine activity is usually 
connected with activation of AC and the increase 
in сAMP level in blood platelets.  
Adding nitroprussid sodium (0.1 mcM) and 
adenosine (2.5 mcM) at the peak of aggregation 
caused platelets disaggregation (Figures 5, 6). The 
concentrations of inducers were selected in 
preliminary experiments with the condition they 
conform to the concentration of agents, when 
maximum amplitude of ADP-induced aggregation 
is 50% compared to control (IC50). In the study of 
the influence of hydrocortisone and prednisolone 
on disaggregation, the preparations were added to 
the sample together with nitroprussid sodium (or 
adenosine) at the peak of aggregation. 
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Fig. 5. The reaction of platelet disaggregation induced by sodium nitroprusside in the absence of (1) and in the presence of SS-68 (2). 
Note. The abscissa is the time, min; On the ordinate axis – change of light transmission, rel. units. Conditions: concentration of sodium 
nitroprusside – 0.1 μM; SS-68 – 10 μM; The number of platelets is 250-350109 cells/l; Mixing speed – 800 rpm; Temperature – 370С 
Fig. 6. Effect of SS-68 on platelet-induced disaggregation induced by adenosine. 
Note. The abscissa is the time, min. On the ordinate axis – change of light transmission, rel. units. Conditions: Adenosine 
concentration 2.5 μM; SS-68 – 10 μM; The number of platelets is 250-350109 cells/l; Mixing speed – 800 rpm; Temperature – 370С 
It was found that SS-68 in concentrations of 1-
10 mcM did not possess any disaggregating activity 
and did not change the platelets response to 
nitroprussid sodium. At the same time, SS-68 dose-
dependently gave potential to adenosine-mediated 
disaggregation of platelets. For instance, with 1 mcM 
of SS-68, IC50 for adenosine was 1.7 mcM, and with 
the SS-68 concentration of 10 mcM, the IC50 value 
was one order less than the original value (0.4 mcM). 
2. The analysis of the SS-68 influence on the
level of calcium ions in platelets. 
The random level of Са2+ in platelets, identified 
with FURA-2/АМ fluorescent dye, was 65±8 нМ. The 
study of the SS-68 influence on [Ca] ic showed that in 
concentration of 1-5 mcM, SS-68 did not cause any 
changes in the random level of calcium ions. 
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Addition of washed collagen platelets (5 
mcg/ml) to the suspension caused an increase in 
intracellular concentration of Са2+ up to 560±72 нМ. 
The growth of calcium level began right after adding 
the inducer, reached its maximum after 2-3 minutes, 
and then the fluorescence gradually declined within 
10 minutes of observation to a new level which was 
significantly higher than the original one.  
To ascertain whether calcium response of sells 
to collagen depends on intracellular ion 
concentration, we compared [Са2+] changes in 
platelets, induced with collagen, in the conventional 
medium containing 1 mcM of CaCl2 and in calcium-
free buffer (0.1 mM EGTA). It was found that in 
calcium-free buffer, the increase in Са2+ was credibly 
lower (148±11 нМ). Therefore, the growth of Са2+ 
level under the influence of collagen takes place 
mainly due to the entry of calcium ions from 
extracellular space.  
To specify the mechanism of the SS-68 activity, 
we used a selective inhibitor Ca
2+
- ATPase reticulum 
thapsigargin. On the background of thapsigargin 
activity (1 mcM), causing emission of Ca
2+ 
from 
intracellular depots and inhibiting its further 
accumulation, any credible influence of SS-68 on 
[Ca]ic was not revealed.  
The study of the SS-68 influence on [Ca]ic 
enabled to state that the credible decrease in the 
random level of calcium was seen only when high 
concentrations (over 10 mcM) of SS-68 were used.  
SS-68 combinations in concentration of 0.5-5.0 
mcM dose-dependently suppressed the growth of 
[Ca] ic caused by collagen (Table 3). The SS-68 effect 
(E) was assessed by measuring the change in the 
amplitude of fluorescence (with excitation 
wavelength 350 nm) and is  expressed in the 
following formula: 
E=(1-F/Fk)100% 
The increase in concentration of SS-68 in the 
incubation medium up to 5-25 mcM resulted in more 
significant changes in the inducer-dependent growth 
of [Ca]IC. 
Table 3 
The SS-68 influence on stimulated calcium level in 
platelets 
Concentration of SS-68, 
mcM 
Са2+ with SS-68 
activity, нМ 
Control 49559 
0.5 35842* 
1 31037* 
5 27633* 
10 22026* 
25 19823* 
Symbols. Са2+ – difference between random and 
collagen-stimulated levels of Са2+. 
* The figures are credible compared to control
(Student t-test p < 0.005). 
The study of time dependency of the Са2+-
blocking effect of hydrocortisone on the collagen-
induced growth of Са2+ revealed the fact that the 
latent period for manifestation of the SS-68 calcium-
blocking activity is not necessary (Table 4).  
Table 4 
Changes in intracellular ion concentration of Са2+ 
induced in human blood platelets with collagen 
(5 mcg/ml) and SS-68 (1 mcM) 
Experimental conditions Са2+, нМ 
Collagen 560±72 
SS-68 2813* 
SS-68 + collagen 
time of pre-incubation: 
5 min 32327** 
15 min 34431** 
30 min 31529** 
Symbols. Са2+ – difference between random and 
collagen-stimulated levels of Са2+. 
* p<0.05 compared to samples containing only collagen;
** p<0.05 compared to samples containing only SS-68. 
The diagram in Figure 7 demonstrates a cascade 
mechanism of platelets activation and possible points 
of SS-68 application on collagen-induced platelet 
aggregation. The process of activation can be divided 
into 5 consecutive biochemical stages [11]. 
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Fig. 7. Cascade mechanism of platelet activation and possible points of application of the action of compound SS-68 
on collagen-induced platelet aggregation. 
Note: – stimulating effect; – inhibitory effect; Arachidonic acid (AA); Platelet activating factor (PAF);
Thromboxane A2 (TxA2); Phosphatidylinositol diphosphate (PIP2); 1,4,5-inositol triphosphate (IP3); Dense tubular system 
(DTS), Diacylglycerol (DAG); Guanosine triphosphate (GTP); Cyclic guanosine monophosphate (cGMP), Adenosine 
triphosphate (ATP); Adenosine diphosphate (ADP); Cyclic adenosine monophosphate (cAMP), Adenosine monophosphate 
(AMP); Calcium-Calmodulin (CaM) 
I. Initiation of activation of the platelet stage of 
hemostasis is determined by formation of a complex 
of collagen with a specific membrane receptor of 
collagen [12]. This interaction results in activation of 
a membrane-bound enzyme of phospholipase A2 with 
formation of arachidonic acid (AA) and lyso-PAF. The 
reaction, catalyzed with an enzyme of thromboxane 
synthetase, produces thromboxane A2 (TxA2) – a 
powerful aggregation inducer and vasoconstrictor. 
Another strong aggregation inducer – a platelet 
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activating factor (PAF) – is produced from an 
intermediate substance – lyso-PAF – through 
enzymatic acetylation with acetyltransferase.  
Thus, two active inducers are produced during 
the first stage of platelets activation, and 1 molecule 
of collagen stimulates the synthesis of about 1000 
molecules of PAF and TxA2. 
II. The auto- and paracrine mechanism of
platelets activation under the influence of PAF and 
TxA2 is mediated by specific membrane receptors and 
is determined by stimulation of the activity of a 
membrane-bound enzyme of phospholipase С [13]. 
The enzymatic hydrolysis of a minor phospholipid of 
phosphatidylinositol diphosphate (PIP2) results in 
formation of two substances – 1,4,5-inositol 
triphosphate (IP3) and diacylglycerol (DAG), 
possessing the qualities of secondary intracellular 
mediators. IP3 – is a hydrophilic chemical which 
mobilizes ionized calcium from its intracellular 
depots: a dense tubular system (DTS), and other 
structures of platelets endoplastic reticulum. In 
resting platelets, the random level of calcium does 
not exceed 80 nM, thereat two pools of calcium are 
distinguished: 1) a cytosolic pool (t1/2 17 min) 
regulated by the Na/Cа transmembrane exchange;  
2) a slowly changing pool (t1/2 300 min) depending
on the activity of Са/Mg- ATPase and localizing in 
DTS. The molecular target of DAG activity is the 
multifunctional membrane-bound enzyme of protein 
kinase C, performing phospholyration of various 
intracellular proteins on serine and threonine 
residues. The regulatory role of PK C consists in 
activation of the intracellular mechanisms of 
decreasing the concentration of free ions of calcium 
in the platelet cytoplasm ([Ca
2+
]ic). These
mechanisms include phospholyration and subsequent 
inhibition of activity of receptor-operated Ca-
channels of the cell membrane.  
Thus, the key stage of stage II platelets 
activation is the mobilization of calcium ions from 
intracellular depots; ionized calcium is the main 
regulator of the sequential platelets activation [14].  
III. The main intracellular processes under
control of intracellular calcium level include: the 
positive modulation activity of membrane 
phospholipase A2 and C; the cell surface expression 
of glycoprotein receptors of fibrinogen, integrin 
complexes (the exposition of some factors of 
adhesion is not a Ca-dependent process); the 
inhibition of adenylate cyclase and guanylate cyclase 
pathways slowing down the stimulation of platelets; 
the work of the platelet contractile apparatus which 
determines the change in the platelet form, adhesion 
activity, and secretion and release of the intracellular 
granules content. 
IV. The stage of degranulation. In the course of
release reaction, through an open tubular system, 
platelets release adenosine diphosphate (ADP), PAF, 
vasopressin, serotonin, adrenalin, and ТхА2, 
involving other platelets in the process of 
aggregation.  
V. The final stages of platelets activation are 
associated with platelets surface expression of 
fibrinogen receptors – a glycoprotein complex of 
IIb/IIa [15].  
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